genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Cancer
Alpine’s Gold Standard Approach to Drug Development
Biomarkers
Precision M&A: Invitae Eyes Growth in Personalized Cancer Tests, Services with…
Gene Therapy
Obsidian’s SWFT Response to COVID-19
Antibody Drug Conjugates
AbCellera’s CEO: Flattening the Curve of Technology Development
Cancer
After Final Medicare LCD from Palmetto GBA, OncoCyte Pursues Private Coverage…
News
Coronavirus
PerkinElmer, Sonora Quest Labs Expand COVID-19 Testing in Arizona
Cancer
From Foe to Friend: Breast Cancer Cells Alter Immune Cells to…
Neuroscience
Could Some of the Benefits of Exercise on the Brain be…
Synthetic Biology
Superhero Bacteria Produce Spider Silk
Bioprocessing
Avantor Expands Life Sciences Innovation Center
Insights
All
Trends for 2020
Coronavirus
Bacteriophages Could Be a Potential Game Changer in the Trajectory of…
Bioprocessing
Digital Biomanufacturing Needs a Digital Supply Chain
Bioprocessing
Continually Collecting Virions for Manufacturing Biotech Products
Bioprocessing
AI Promises to Accelerate Process Characterization
A-Lists
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Coronavirus
Catching Up to Coronavirus: Top 60 Treatments in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Cancer
From Foe to Friend: Breast Cancer Cells Alter Immune Cells to…
Synthetic Biology
Superhero Bacteria Produce Spider Silk
Bioprocessing
Avantor Expands Life Sciences Innovation Center
Upcoming Webinars
Uncover the True Identity of Your Particles with Comprehensive Particle Investigation
Magazine
July 2020 Vol. 40 No. 7
Rosalind Franklin the Scientist
July 2020 Vol. 40 No. 7
COVID-19 Research: Women Are Changing the Face of the Pandemic
July 2020 Vol. 40 No. 7
CRISPR Screening Explores New Dimensions
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
Commentary
Clues to Healthier Aging in Cellular Senescence
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Keynote Webinars
Life in the Time of Coronavirus
Upcoming Webinars
Uncover the True Identity of Your Particles with Comprehensive Particle Investigation
On Demand Webinars
GEN Live: COVID-19: Talking Next-Gen Diagnostics
Tutorial
Cultivation of Diverse and Rare Bacteria from Human Gut Microbiome
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Companies
Roche
Roche
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Roche
Phase III Trial to Study Combination of Genentech’s Actemra, Gilead’s Remdesivir vs. Severe COVID-19
Roche
Genentech Launches Phase III Trial of Actemra as Coronavirus Treatment
Roche
Declaring National Emergency, Trump Vows Accelerated COVID-19 Testing
Roche
Assessing Coronavirus Impact on Wall Street
Roche
Illumina, Roche Launch NGS-Based Cancer Diagnostics Partnership
Roche
Illumina Unveils New Sequencing Systems, Roche Clinical Dx Collaboration
Roche
Roche Buys Ex-U.S. Rights to Sarepta DMD Gene Therapy Candidate SRP-9001...
Roche
Roche to Expand Fibrotic Disease Pipeline with Up-to-$1.4B Promedior Acquisition
Roche
Roche, Dicerna Launch Up-to-$1.67B Hepatitis B Collaboration
Roche
Genmab Files for $500M U.S. IPO, Seeking to Launch a Proprietary...
Roche
Roche Extends Offer for Spark Therapeutics a Second Time, as Shareholders...
Roche
FDA Approves Tecentriq-Abraxane Combo as First Immunotherapy Regimen for Breast Cancer
Roche
Roche-Licensed Rare Disease Drug at Center of Ipsen’s Up-to-$1.3B Clementia Acquisition
Roche
Roche Expands into Gene Therapy with Planned $4.8B Acquisition of Spark...
Roche
Genentech to Develop Xencor IL-15 Cytokines in Immuno-Oncology Partnership
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
